Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD

Int J Chron Obstruct Pulmon Dis. 2019 Mar 1:14:585-595. doi: 10.2147/COPD.S195438. eCollection 2019.

Abstract

Purpose: Adequate peak inspiratory flow rate (PIFR) is required for drug dispersion with dry powder inhalers (DPIs). Prevalence of PIFR discordance (suboptimal PIFR with prescribed inhalers) and factors influencing device-specific PIFR are unclear in COPD. The objective of this study was to determine the prevalence of PIFR discordance and associated clinical factors in a stable COPD population.

Patients and methods: An observational, single-center, cohort study was conducted including 66 outpatients with COPD. PIFR was measured using the In-Check™ Dial with applied resistance of prescribed inhalers. Participants were defined as discordant if measured PIFR was <30 L/min and <60 L/min for high and low-medium resistance devices, respectively, using an inspiratory effort the participant normally used with their prescribed DPI.

Results: The median age of the COPD participants was 69.4 years, 92% were white and 47% were female. A total of 48% were using low-medium resistance DPIs (Diskus®/Ellipta®) and 76% used high-resistance DPI (Handihaler®). A total of 40% of COPD participants were discordant to prescribed inhalers. Female gender was the only factor consistently associated with lower PIFR. Shorter height was associated with reduced PIFR for low-medium resistance (r=0.44; P=0.01), but not high resistance (r=0.20; P=0.16). There was no correlation between PIFR by In-Check™ dial and PIFR measured by standard spirometer.

Conclusion: PIFR is reduced in stable COPD patients, with female gender being the only factor consistently associated with reduced PIFR. Discordance with prescribed inhalers was seen in 40% of COPD patients, suggesting that many COPD patients do not generate adequate inspiratory force to overcome prescribed DPIs resistance in the course of normal use.

Keywords: chronic obstructive; drug delivery systems; dry powder inhaler; peak inspiratory flow rate; pulmonary disease.

Publication types

  • Observational Study

MeSH terms

  • Administration, Inhalation
  • Aged
  • Aged, 80 and over
  • Airway Resistance
  • Bronchodilator Agents / administration & dosage
  • Dry Powder Inhalers
  • Female
  • Forced Expiratory Volume
  • Humans
  • Inhalation*
  • Lung / drug effects
  • Lung / physiopathology*
  • Male
  • Middle Aged
  • North Carolina / epidemiology
  • Prevalence
  • Prospective Studies
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Risk Factors
  • Sex Factors
  • Spirometry
  • Vital Capacity

Substances

  • Bronchodilator Agents